Portfolio company
CoreValve SA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops trans-catheter aortic valve replacement systems for patients with severe aortic stenosis who are unsuitable for open-heart surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
JenaValve
This medical device company develops transcatheter heart valve replacement systems for patients suffering from symptomatic aortic regurgitation and aortic stenosis.
CroiValve
The company develops a transcatheter heart valve system to treat tricuspid regurgitation in patients unsuitable for open-heart surgery.
CroíValve
The company develops a minimally invasive transcatheter valve system to treat tricuspid regurgitation for elderly and frail cardiac patients.
Valcare Medical
The company develops transcatheter repair and replacement technologies for heart valves to treat patients with mitral and tricuspid regurgitation.
CardiAQ Valve Technologies (CVT)
This company develops transcatheter mitral valve replacement systems to treat heart disease patients through minimally invasive procedures.
Coramaze
This medical technology company develops a transcatheter valve repair system for treating patients with tricuspid regurgitation and other structural heart conditions.
Pi-Cardia
This company develops non-implant catheter devices that modify heart valve leaflets to treat calcification and facilitate valve replacement procedures for cardiac patients.